You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 266 No. 5, August 7, 1991 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Brief Report
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (121)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Pyridostigmine Used as a Nerve Agent Pretreatment Under Wartime Conditions

LTC Jill R. Keeler, AN; COL Charles G. Hurst, MC; COL Michael A. Dunn, MC

JAMA. 1991;266(5):693-695.


Abstract

Objective.
—To determine the adverse effects of pretreatment with pyridostigmine bromide for nerve agent exposure during wartime.

Design.
—A retrospective study.

Setting.
—Southwest Asia.

Participants.
—Personnel who provided medical support to the XVIII Airborne Corps. These medical officers supplied information pertaining to symptoms and disposition of 41 650 soldiers who received pyridostigmine at the onset of hostilities of Operation Desert Storm.

Intervention.
—Pyridostigmine bromide, 30 mg orally, was self-administered every 8 hours while under the threat of nerve agent attack (for 1 to 7 days).

Main Outcome Measure.
—Physiologic changes attributable to pyridostigmine that resulted in need for medical attention, discontinuation of the drug, hospitalization, and/or evacuation from Southwest Asia.

Results.
—About half of the population noted physiologic changes that were not incapacitating, such as increased flatus, abdominal cramps, soft stools, and urinary urgency. Approximately 1% of the soldiers believed they had effects that warranted medical attention, but fewer than 0.1% had effects sufficient to discontinue the drug. Nonincapacitating symptoms often occurred; however, military mission performance was not impaired.

Conclusion.
—While under the threat of nerve agent attack, pyridostigmine can be administered to virtually all soldiers.

(JAMA. 1991;266:693-695)



Author Affiliations

From the US Army Medical Research Institute of Chemical Defense, Aberdeen Proving Ground, Md.


Footnotes

Reprint requests to Commander, US Army Medical Research Institute of Chemical Defense, ATTN: SGRDUV-YY/LTC Keeler, Aberdeen Proving Ground, MD 21010-5425.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Effect of acetylcholinesterase inhibition with pyridostigmine on cardiac parasympathetic function in sedentary adults and trained athletes
Dewland et al.
Am. J. Physiol. Heart Circ. Physiol. 2007;293:H86-H92.
ABSTRACT | FULL TEXT  

Pyridostigmine, Diethyltoluamide, Permethrin, and Stress: A Double-Blind, Randomized, Placebo-Controlled Trial to Assess Safety
Roy et al.
Mayo Clin Proc. 2006;81:1303-1310.
ABSTRACT | FULL TEXT  

Enhanced heart rate variability and baroreflex index after stress and cholinesterase inhibition in mice
Joaquim et al.
Am. J. Physiol. Heart Circ. Physiol. 2004;287:H251-H257.
ABSTRACT | FULL TEXT  

Nerve Agents: A Comprehensive Review
Wiener and Hoffman
J Intensive Care Med 2004;19:22-37.
ABSTRACT  

Delayed Neurologic and Behavioral Effects of Subtoxic Doses of Cholinesterase Inhibitors
Scremin et al.
J. Pharmacol. Exp. Ther. 2003;304:1111-1119.
ABSTRACT | FULL TEXT  

Acute and Repeated Restraint Stress Have Little Effect on Pyridostigmine Toxicity or Brain Regional Cholinesterase Inhibition in Rats
Song et al.
Toxicol Sci 2002;69:157-164.
ABSTRACT | FULL TEXT  

A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases
Shapira et al.
Hum Mol Genet 2000;9:1273-1281.
ABSTRACT | FULL TEXT  

Violations of Informed Consent During War
Schofer
JAMA 1999;281:1657-1657.
FULL TEXT  

Persistently Exaggerated Startle Responses in Rats Treated with Pyridostigmine Bromide
Servatius et al.
J. Pharmacol. Exp. Ther. 1998;287:1020-1028.
ABSTRACT | FULL TEXT  

Self-reported Exposure to Neurotoxic Chemical Combinations in the Gulf War: A Cross-sectional Epidemiologic Study
Haley and Kurt
JAMA 1997;277:231-237.
ABSTRACT  

Effect of pyridostigmine pretreatment on cardiorespiratory function in tabun poisoning
Worek et al.
Hum Exp Toxicol 1995;14:634-642.
ABSTRACT  

Unexplained Illnesses Among Desert Storm Veterans: A Search for Causes, Treatment, and Cooperation
Persian Gulf Veterans Coordinating Board et al.
Arch Intern Med 1995;155:262-268.
ABSTRACT  

Study of muscular effects of short-term pyridostigmine treatment in resting and exercising rats
Hubert and Lison
Hum Exp Toxicol 1995;14:49-54.
ABSTRACT  

More on Desert Storm
Sarno
JAMA 1991;266:3282-3282.
ABSTRACT  

More on Desert Storm
Neish and Carter
JAMA 1991;266:3282-3283.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.